Proteoglycans, especially heparan sulfate-substituted species, are known to be associated with the deposition of amyloid in Alzheimer's disease. We previously found that heparan sulfate from afflicted brains, and from control subjects, differed minimally in quantity and structure (Lindahl, B., Eriksson, L., and Lindahl, U. (1995) Biochem. J. 306, 177-184). In the present study, a glycosaminoglycan fraction, shown to contain heparan sulfate and keratan sulfate, was radiolabeled by partial N-deacetylation (hydrazinolysis) followed by re-Nacetylation using [ 3 H]acetic anhydride. Quantitation of the 3 H-labeled polysaccharides, based on digestion with heparitinase I from Flavobacterium heparinum and keratanase from Pseudomonas sp., revealed that the amounts of keratan sulfate in Alzheimer cerebral cortex are reduced to less than half of control values. Moreover, a monoclonal antibody against a highly sulfated keratan sulfate epitope bound to the majority of the neurons in normal cortex but not in the diseased tissue. The lack of highly sulfated keratan sulfate structures may reflect a specific functional defect of the cells.Alzheimer's disease (AD) 1 is characterized by amyloid deposits in the cerebral parenchyma, the occurrence of neurofibrillary tangles in the perinuclear cytoplasm of neurons, and by neuronal degeneration. Proteoglycans, especially heparan sulfate (HS)-substituted species, are known to be associated with the amyloid deposits (1). In a previous study, we found that heparan sulfate isolated from afflicted brains, and from control subjects, differed minimally in quantity and structure (2). Keratan sulfate (KS), originally demonstrated in cornea and cartilage, was more recently identified in brain (3). KS is a linear polymer of 1,3-linked N-acetyl-lactosamine (Gal1,4GlcNAc) disaccharide units that are sulfated to a variable degree on the C-6 positions of either the glucosamine or galactose residues (Fig. 1). While a limited number of KSproteoglycans have since been isolated from brain (4), there are no reports to our knowledge concerning the distribution or characteristics of KS or KS-proteoglycans in AD.Here we report that contrary to HS, KS, isolated together with the HS glycosaminoglycan fraction, is dramatically decreased in cerebral cortex of Alzheimer patients. This finding is paralleled by the loss of epitopes recognized by a monoclonal antibody with specificity for highly sulfated KS. The specific staining of normal neurons and the lack of these highly sulfated KS structures in afflicted neurons may reflect a specific functional defect of the neurons in AD.
MATERIALS AND METHODSIsolation and Radiolabeling of Glycosaminoglycans-Sulfated glycosaminoglycans (GAGs) were isolated as described (2) from samples of cerebral cortex obtained at autopsy of control subjects and of individuals with the clinical diagnosis and typical neuropathological findings (2, 5) of AD. Briefly, the procedure involved lipid extraction, proteolytic digestion, and anion-exchange chromatography. Material more retarded...